Pennsylvania 2025_0 Regular Session Status: Passed Senate Bipartisan · 2 R · 2 D cosponsors

SB 866 — An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for schedules of controlled substances and for secure storage of xylazine; and adding provisions relating to medetomidine.

Last action — Referred to JUDICIARY, June 10, 2026

Track this bill free

No card. One bill, free forever — alerts when it moves.

  1. ✓
    Introduced
  2. ✓
    In Committee
  3. 3
    Passed Senate
  4. 4
    Passed House
  5. 5
    To Executive
  6. 6
    Enacted

This bill has passed the Senate. Introduced July 24, 2025. It now moves to the second chamber.

Next likely step: consideration and a floor vote in the House.

Prognosis

Likely to advance 70% · high confidence

Where this bill stands today.

Odds of enactment

Moderate

How often bills like it became law.

  • Passed Senate

    Current position in the legislative process.

  • 4 sponsors

    1 primary, 3 co-sponsors signed on.

  • Bipartisan support

    Sponsored across 2 parties (2 R · 2 D) — cross-party backing.

  • Cleared a recorded vote

    Passed 1 recorded vote so far.

Prognosis reads this bill's own signals — stage, sponsorship breadth, committee status, recorded votes and cross-state momentum. Odds come from a model trained on which bills have become law.

In plain language

This bill classifies medetomidine as a controlled substance and regulates its possession.

The bill amends laws on controlled substances to classify medetomidine as Schedule III, restricting its possession. It includes exemptions for veterinary use.

What this means for you
  • Workers: Workers in veterinary medicine will need to stay informed about regulations regarding medetomidine use.
  • Healthcare: Veterinary practitioners can still use medetomidine legally, but unauthorized possession is restricted.

Summary

Scheduling Medetomidine as a Schedule III Controlled Substance in PA and Criminalizing the Illicit Possession, with Veterinary Use Exemptions

Bill Text

How this bill changes current law

2 changes Share ↗

AI-generated reading aid from the bill's amendatory text — verify against the official bill.

The bill adds medetomidine to Schedule III of controlled substances and outlines specific exemptions for its use, while updating storage requirements for medetomidine and xylazine.

  • Section 4(3)

    (xii) Medetomidine, including any compound, mixture or preparation which contains any quantity of the substances referred to in this clause. (xiii) Medetomidine as described in subclause (xii) is not a controlled substance when used in any of the following manners: 1. Dispensing or prescribing for, or administering to, a nonhuman species of a drug containing medetomidine that: (A) has been approved by the United States Secretary of Health and Human Services under 21 U.S.C. § 360b (relating to new animal drugs); or (B) is authorized under 21 U.S.C. § 360b(a)(4). 2. The manufacturing, distribution or use of medetomidine as an active pharmaceutical ingredient for manufacturing an animal drug approved under 21 U.S.C. § 360b or an animal drug that has been issued an investigation use exemption under 21 U.S.C. § 360b(j). 3. The manufacturing, distribution or use of a medetomidine bulk chemical for pharmaceutical compounding by a licensed pharmacist or veterinarians. 4. Any other use approved or authorized under 21 U.S.C. Ch. 9 (relating to Federal Food, Drug, and Cosmetic Act). 5. Another use approved or permissible under Federal or State law.

    This change adds medetomidine to the list of controlled substances with specific exemptions for certain uses.

  • Section 13.9

    A practitioner who is a veterinarian shall comply with the provisions of section 4(a)(5) of the act of September 27, 1961 (P.L.1700, No.699), known as the "Pharmacy Act," for the storage and protection of medetomidine and xylazine.

    This addition requires veterinarians to follow specific storage and protection protocols for medetomidine and xylazine.

Action History

  1. Referred to JUDICIARY, June 10, 2026

  2. In the House

  3. (Remarks see Senate Journal Page 398-399), June 9, 2026

  4. Third consideration and final passage, June 9, 2026 (47-2)

  5. Re-reported as committed, June 8, 2026

  6. Re-referred to APPROPRIATIONS, June 3, 2026

  7. Second consideration, June 3, 2026

  8. First consideration, June 2, 2026

  9. Reported as committed, June 2, 2026

  10. Referred to AGRICULTURE AND RURAL AFFAIRS, July 24, 2025

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 3 co-sponsors · 249 not signed on · 2 voted No

Sponsors (1)

Co-sponsors (3)

Not signed on (249)

249 members have not signed on to this bill.

Show all 249 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Votes

Final Passage

Passed 47 Yea · 2 Nay · 1 Other
Party YeaNayPresentNot Voting
Republican 27000
Democratic 20200
Unaffiliated 0001
Total 47201
% of votes cast 94%4%0%2%
How each member voted (50)
Member Party Vote
Anthony Williams — Not Voting
Amanda M. Cappelletti Democratic Yea
Art Haywood Democratic Yea
Carolyn T. Comitta Democratic Yea
Christine M. Tartaglione Democratic Yea
James Andrew Malone Democratic Yea
Jay Costa Democratic Yea
John I. Kane Democratic Yea
Judith L. Schwank Democratic Yea
Katie J. Muth Democratic Yea
Lindsey M. Williams Democratic Yea
Lisa M. Boscola Democratic Yea
Maria Collett Democratic Yea
Marty Flynn Democratic Yea
Nick Miller Democratic Yea
Nick Pisciottano Democratic Yea
Nikil Saval Democratic Nay
Patty Kim Democratic Yea
Sharif Street Democratic Yea
Steven J. Santarsiero Democratic Yea
Timothy P. Kearney Democratic Nay
Vincent J. Hughes Democratic Yea
Wayne D. Fontana Democratic Yea
Camera Bartolotta Republican Yea
Chris Gebhard Republican Yea
Cris Dush Republican Yea
Daniel Laughlin Republican Yea
David G. Argall Republican Yea
Dawn W. Keefer Republican Yea
Devlin J. Robinson Republican Yea
Doug Mastriano Republican Yea
Elder A. Vogel Republican Yea
Frank A. Farry Republican Yea
Gene Yaw Republican Yea
Greg Rothman Republican Yea
Jarrett Coleman Republican Yea
Joe Picozzi Republican Yea
Joe Pittman Republican Yea
Judy Ward Republican Yea
Kim L. Ward Republican Yea
Kristin Phillips-Hill Republican Yea
Lisa Baker Republican Yea
Lynda Schlegel Culver Republican Yea
Michele Brooks Republican Yea
Patrick J. Stefano Republican Yea
Rosemary M. Brown Republican Yea
Scott E. Hutchinson Republican Yea
Scott Martin Republican Yea
Tracy Pennycuick Republican Yea
Wayne Langerholc Republican Yea

Official roll call →

Subjects

Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does SB 866 do?
Scheduling Medetomidine as a Schedule III Controlled Substance in PA and Criminalizing the Illicit Possession, with Veterinary Use Exemptions
Who sponsors SB 866?
SB 866 is sponsored by Michele Brooks (Republican), Doug Mastriano (Republican), Christine M. Tartaglione (Democratic), and Lisa M. Boscola (Democratic).
What is the current status of SB 866?
This bill has passed the Senate. Introduced July 24, 2025. It now moves to the second chamber.
Where can I track SB 866?
Track SB 866 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on SB 866

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Stay ahead of SB 866

Last checked for changes 3 days ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →